Zetta Genomics has expanded its second seed round, attracting new investment and growth expertise. With £6.2 million secured over two years, Zetta scales global operations and customer offerings to transform precision medicine and personalised healthcare.    Fast-scaling genomic data pioneer, Zetta Genomics, has expanded its second seed round – securing an additional £1.8 million and strengthening investor expertise. […]

SOPHiA GENETICS and AstraZeneca Spain expand HRD testing program to support molecular diagnosis of ovarian cancer in Spain Boston, MA, Rolle, Switzerland and Madrid, Spain – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced it has expanded an existing program in Spain to increase access to local testing for homologous recombination […]

Direct integration allows customers to stream data from Element’s AVITI™ System directly to DNAnexus SAN DIEGO, CA – Element Biosciences, Inc., developer of pioneering technologies to empower science, announced a collaboration with DNAnexus, provider of the Precision Health Data Cloud, to allow customers to stream data from Element’s AVITI™ System directly to their DNAnexus account. The collaboration combines the […]

BOZEMAN, Mont — Golden Helix, Inc. announced that it has received the certification for ISO 13485:2016 from TÜV SÜD. ISO 13485:2016 is an international standard that specifies requirements for a quality management system (QMS) for organizations involved in the design, development, production, and servicing of medical devices. It is specifically tailored to the medical device industry […]

New software accelerator significantly reduces time and cost of NGS secondary analysis for somatic cancer, analyzing a 275-gene comprehensive cancer panel at 3377x coverage in just 6 minutes for less than $0.72 per test  Included in market-leading CLC Genomics analysis platform for desktop, server or cloud use Enhances QDI’s leading portfolio of NGS analysis and […]

The company announced Bioma4me has implemented SOPHiA DDM™ to support its rare disorder testing capabilities Boston, MA and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Bioma4me, a Brazil-based company focused on genetic sequencing to drive precision medicine to the Brazilian […]

Trusted research environment provides secure access to high-quality, de-identified whole genome sequencing data and associated medical records MOUNTAIN VIEW, Calif. & BOSTON — DNAnexus, Inc., the provider of the Precision Health Data Cloud, and TMA Precision Health, a global health platform for rare diseases, today announced a collaboration to advance basic and translational research for patients […]

Analysis platform enables powerful, accessible single cell data exploration SEATTLE — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced it has acquired data analysis software company Biomage. With the acquisition, customers will have access to a richer suite of single cell data analysis tools through an intuitive interface. By […]

SOPHiA GENETICS technology helps advance cancer research across India SOPHiA GENETICS and Karkinos Healthcare join forces to propel cutting-edge genomic solutions for breakthroughs in personalized cancer care in India Boston, MA and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that Karkinos Healthcare, a purpose-driven […]

Leading bioinformatics software company Qlucore has agreed a two-year license with the large pharmaceutical company Boehringer Ingelheim worth approximately 1.67 million SEK. As a leading pharmaceutical company engaged in research and development across multiple locations worldwide and a previous customer of Qlucore, the license enables global utilization of Qlucore Omics Explorer software. Qlucore Omics Explorer is […]